Gutenberg Technology is a Franco-American B2B SaaS company that builds an end-to-end Learning Content Management System (LCMS) and AI-powered authoring tools. Its MobileFirst platform lets publishers, universities, and enterprises author, transform, reuse, and distribute print and digital learning content from a single workflow. Trusted by names like Cengage, National Geographic Learning, Vista Higher Learning, and CompTIA, the platform has powered 230,000+ learning assets reaching 7+ million learners, and in 2025 launched an AI Course Builder that converts existing documents into structured eLearning modules.
InterVenn Biosciences is a South San Francisco biotech building an AI-driven glycoproteomics platform that reads the sugar coatings on proteins to detect disease earlier. Its flagship blood test, GlycoKnow Ovarian, distinguishes ovarian cancer from benign pelvic masses with ~86% accuracy and went commercial in 2025. Founded in 2017 by Aldo Carrascoso with chemists Carolyn Bertozzi (Nobel Laureate) and Carlito Lebrilla, the company has raised roughly $244M, including a $201M Series C led by SoftBank in 2021.